Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.

Klinghoffer RA, Bahrami SB, Hatton BA, Frazier JP, Moreno-Gonzalez A, Strand AD, Kerwin WS, Casalini JR, Thirstrup DJ, You S, Morris SM, Watts KL, Veiseh M, Grenley MO, Tretyak I, Dey J, Carleton M, Beirne E, Pedro KD, Ditzler SH, Girard EJ, Deckwerth TL, Bertout JA, Meleo KA, Filvaroff EH, Chopra R, Press OW, Olson JM.

Sci Transl Med. 2015 Apr 22;7(284):284ra58. doi: 10.1126/scitranslmed.aaa7489.

2.

Distinct neuroinflammatory profile in post-mortem human Huntington's disease.

Silvestroni A, Faull RL, Strand AD, Möller T.

Neuroreport. 2009 Aug 5;20(12):1098-103. doi: 10.1097/WNR.0b013e32832e34ee.

PMID:
19590393
3.

Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.

Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM, Jones KR.

J Neurosci. 2007 Oct 24;27(43):11758-68.

4.

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.

Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, Albin R, Shelbourne P, Delorenzi M, Augood SJ, Faull RL, Olson JM, Bates GP, Jones L, Luthi-Carter R.

Hum Mol Genet. 2007 Aug 1;16(15):1845-61. Epub 2007 May 21.

PMID:
17519223
5.

Conservation of regional gene expression in mouse and human brain.

Strand AD, Aragaki AK, Baquet ZC, Hodges A, Cunningham P, Holmans P, Jones KR, Jones L, Kooperberg C, Olson JM.

PLoS Genet. 2007 Apr 20;3(4):e59.

6.

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD, Cui L, Beyer RP, Easley CN, Smith AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, La Spada AR.

Cell Metab. 2006 Nov;4(5):349-62. Epub 2006 Oct 19.

7.

Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data.

Jones L, Goldstein DR, Hughes G, Strand AD, Collin F, Dunnett SB, Kooperberg C, Aragaki A, Olson JM, Augood SJ, Faull RL, Luthi-Carter R, Moskvina V, Hodges AK.

BMC Bioinformatics. 2006 Apr 19;7:211.

8.

Regional and cellular gene expression changes in human Huntington's disease brain.

Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R.

Hum Mol Genet. 2006 Mar 15;15(6):965-77. Epub 2006 Feb 8.

PMID:
16467349
9.

Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Benn CL, Landles C, Li H, Strand AD, Woodman B, Sathasivam K, Li SH, Ghazi-Noori S, Hockly E, Faruque SM, Cha JH, Sharpe PT, Olson JM, Li XJ, Bates GP.

Hum Mol Genet. 2005 Oct 15;14(20):3065-78. Epub 2005 Sep 23.

PMID:
16183657
10.

Significance testing for small microarray experiments.

Kooperberg C, Aragaki A, Strand AD, Olson JM.

Stat Med. 2005 Aug 15;24(15):2281-98.

PMID:
15889452
11.

Gene expression in Huntington's disease skeletal muscle: a potential biomarker.

Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM.

Hum Mol Genet. 2005 Jul 1;14(13):1863-76. Epub 2005 May 11.

PMID:
15888475
12.

Genetic heterogeneity of stably transfected cell lines revealed by expression profiling with oligonucleotide microarrays.

Oh MK, Scoles DR, Haipek C, Strand AD, Gutmann DH, Olson JM, Pulst SM.

J Cell Biochem. 2003 Dec 1;90(5):1068-78.

PMID:
14624465
13.

BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.

Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM.

Nat Med. 2003 Aug;9(8):1033-8. Epub 2003 Jul 20.

PMID:
12872164
14.

Evaluating test statistics to select interesting genes in microarray experiments.

Kooperberg C, Sipione S, LeBlanc M, Strand AD, Cattaneo E, Olson JM.

Hum Mol Genet. 2002 Sep 15;11(19):2223-32.

PMID:
12217950
15.

Estimating the statistical significance of gene expression changes observed with oligonucleotide arrays.

Strand AD, Olson JM, Kooperberg C.

Hum Mol Genet. 2002 Sep 15;11(19):2207-21.

PMID:
12217949
16.

Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.

Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH.

Hum Mol Genet. 2002 Aug 15;11(17):1967-76.

PMID:
12165558
17.

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

Luthi-Carter R, Strand AD, Hanson SA, Kooperberg C, Schilling G, La Spada AR, Merry DE, Young AB, Ross CA, Borchelt DR, Olson JM.

Hum Mol Genet. 2002 Aug 15;11(17):1927-37.

PMID:
12165555
18.

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.

Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM.

Hum Mol Genet. 2002 Aug 15;11(17):1911-26.

PMID:
12165554
19.

Altered transcription in yeast expressing expanded polyglutamine.

Hughes RE, Lo RS, Davis C, Strand AD, Neal CL, Olson JM, Fields S.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13201-6. Epub 2001 Oct 30.

20.

Supplemental Content

Loading ...
Support Center